Online Safety Community

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects for a number of valid reasons. One of the main reasons is that medical device regulatory and quality professionals are often responsible for overseeing the development of combination products that include small or large drug “active pharmaceutical ingredients” to achieve the clinical therapeutic effect.

In many pharmaceutical organizations, the medical device professional is often expected to take the lead role in overseeing all aspects of regulatory and quality compliance, including Chemistry, Manufacturing and Controls (CMC) aspects, particularly when the “primary mode of action” (PMOA) relates to the device component. It is here that Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects, because Regulatory and Quality engineers are often ill-equipped to manage the CMC aspects of projects.

This is because being technically trained personnel; they have scant knowledge of even the basic functions of the chemical, molecular structural, drug manufacturing process and analytical methods associated with the "active pharmaceutical ingredient" component.

Need to be able to understand technical elements of medical devices and combination drugs

Yet, that medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects cannot be ruled out, because since subtle chemical issues are integrally related to product performance, they need to be able to understand technical elements of medical devices and combination drugs.

The professional in charge of Regulatory Affairs (RA) needs to have a clear understanding of how drug chemistry impacts drug/device performance. The RA Lead needs to have answers to questions relating to:

o  The proper storage and environmental condition for simple molecules, peptides, polypeptides and proteins

o  The ways in which the drug impurity levels change as the product is combined with the device components

o  The way “Quality by Design” (QbD) ensures drug performance

o  The methods by which an analytical method should be validated to meet FDA CDER requirements

o  The indicia of drug stability

Since it is questions such as these that frequently arise during FDA product evaluation, Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects.

A major learning session to help understand these aspects

Compliance4All, a leading provider of professional trainings for all the areas of regulatory compliance, will organize a learning session to help understand these aspects, at which these and related aspects of managing drug and device combination product project will be imparted.

The speaker at this webinar is Robert Michalik J.D, RAC, a Massachusetts regulatory attorney and founder of RegulatoryPro.com, a consulting firm providing general and specialized services to the biopharmaceutical and medical device industries. To enrol for this webinar, please visit

http://www.compliance4all.com/control/w_product/~product_id=501077L...

Robert will familiarize participants with the basics of small molecule and larger molecule (protein chemistry) development and testing. Using this as the basis, he will offer real world practical situations that arise in this field, which will help participants to become aware of how to spot problems that are a routine occurrence in every product development program. Being able to spot a CMC problem is more important than having the knowledge to fix it, because the FDA does not expect a company to solve it, but rather that it understands how the agency locates the problem.

Robert will cover the following areas at this session:

Chemistry 101: A review of the basics

  • Molecular structure and its impact on drug activity (smaller molecules behave differently from larger molecules)
  • Techniques commonly used in drug synthesis, manufacturing and quality control testing.
  • CMC Regulatory Compliance: Brief but comprehensive review of the essentials
  • How to spot a CMC-related problem and what to do when you suspect one.
  • Case studies that illustrate common issues that arise relating to drug components in combination device products
  • FAQs and Essential follow-up reading for those who want more resources

Views: 13

Comment

You need to be a member of Online Safety Community to add comments!

Join Online Safety Community

Take our poll!

Take our poll!

Latest Activity

Profile IconReshma Juhi, Melissa Kopoulos and Liton Mazumder joined Online Safety Community
11 hours ago
Adam Fleaming posted a blog post

Webinar Calendar of Upcoming Courses - May to Jun 2017

Below is the event description content:Compliance4All webinars are just what professionals in the regulatorycompliance areas need for scaling up in their careers. With a collection ofthe most erudite experts on regulatory compliance being available at a clickin the comfort of your preferred location; regulatory compliance could notget any simpler and effective! Compliance4All’s experts help you unravel all the knowledge you need in allthe areas of regulatory compliance. They help professionals…See More
15 hours ago
Roger Steven posted a blog post

Understanding CARC and RARC

A Claim Adjustment Reason Code (CARC) is a code used in medical billing to communicate a change or an adjustment in payment. CARCs have to be used to communicate why there was a difference between the amount paid in a claim or service line and the amount that was billed against it. CARCS are to be mentioned only if there is an adjustment of this kind. If there is no adjustment to a claim or…See More
Friday
kate smith posted a blog post

Diligence and scrutiny are important for writing investigative reports

Diligence and a high degree of scrutiny are crucial for a person who is writing investigative reports in an organization. In the first place, an investigation has to be objective and not be vindictive. It should avoid targeting an employee personally; it should be thorough and proper from a legal perspective. When all the legal procedures are followed in an investigation, the case of the employer becomes strong and defensible…See More
Friday

Forum

What's your favorite motivational/safety quote? 98 Replies

Favorite Motivational Quote: If you want something, you'll find a way - If not, you'll find an excuse.Favorite Safety Quote: Don't learn safety by accident!Continue

Started by Michelle Sears. Last reply by David R Snell Apr 26.

Feedback on a injury prevention product we're building.

Hi everyone!For full transparency ill tell you a little about myself and what I hope to accomplish. My name is Zuber and I'm an engineering student who founded a startup helping to build wearable…Continue

Tags: product, prevention, injury, back, safety

Started by Zuber Ahmed Apr 24.

Best overall personal safety book? 1 Reply

What do you think is  the best all-in-one book out there for optimizing personal safety and the safety of one's family?  Right now I have …Continue

Started by David R Snell. Last reply by David R Snell Apr 21.

Fire codes for residential buildings

Hi,Can anybody kindly give me a hint how to find Fire Codes for residential buildings in different cities in the United States?Continue

Started by Darren Asad Apr 14.

OSHA and Machine Guard Door Safety???

We have what we feel is not a unique situation and were wondering if anyone might of run across this challenge and know more about the requirements.  We are building a small machine system that…Continue

Tags: electric, osha, air, door, interlocked

Started by Scott V Mar 24.

Badge

Loading…

© 2017   Created by Safety Community.   Powered by

Badges  |  Report an Issue  |  Terms of Service